ReviewInternational journal of nanomedicine2026
Concept of 2D van der Waals Nanohybrids for Key Biomedical Applications.
Review in International journal of nanomedicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The past decade has witnessed a fundamental shift in 2D nanomaterials, from isolated single-component sheets to vdW nanohybrids, architected as stacked, stitched, or surface-engineered assemblies of chemically distinct layers. Enabled by weak interlayer forces, these hybrids permit modular integration of photonic, catalytic, electronic, and bioactive functions without lattice matching or harsh chemistries. In biomedicine, this modularity is transformative: one layer can absorb Near Infrared, NIR light for photothermal or photodynamic therapy, another can intercalate and release drugs or nucleic acids, a third can modulate redox biology through ROS scavenging or nanozyme activity, while polymeric or biomimetic coatings provide immune evasion, targeting, or biodegradability. Compared with isotropic nanoparticles, 2D vdW interfaces offer maximal surface area, multivalent binding, anisotropic ion/electron transport, tissue-compliant mechanics, and engineerable interlayer galleries for controlled, stimulus-responsive release. Crucially, vdW stacking preserves the intrinsic properties of each layer while enabling emergent synergistic behaviors including photothermal-photodynamic coupling, catalytic-photonic amplification, mechanobiology-driven responsiveness, and staged therapeutic logic. Together, these attributes position vdW nanohybrids as a powerful and versatile class of materials poised to redefine therapeutic, diagnostic, regenerative, and bioelectronic frontiers in next-generation nanomedicine.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.